Copyright Reports & Markets. All rights reserved.

Global Mammalian Process Development Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Mammalian Process Development by Type
    • 1.3.1 Overview: Global Mammalian Process Development Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Mammalian Process Development Consumption Value Market Share by Type in 2025
    • 1.3.3 Upstream Process Development
    • 1.3.4 Downstream Process Development
  • 1.4 Global Mammalian Process Development Market by Application
    • 1.4.1 Overview: Global Mammalian Process Development Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Vaccine Development
    • 1.4.3 Biosimilar Drug Development
    • 1.4.4 Others
  • 1.5 Global Mammalian Process Development Market Size & Forecast
  • 1.6 Global Mammalian Process Development Market Size and Forecast by Region
    • 1.6.1 Global Mammalian Process Development Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Mammalian Process Development Market Size by Region, (2021-2032)
    • 1.6.3 North America Mammalian Process Development Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Mammalian Process Development Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Mammalian Process Development Market Size and Prospect (2021-2032)
    • 1.6.6 South America Mammalian Process Development Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Mammalian Process Development Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Lonza
    • 2.1.1 Lonza Details
    • 2.1.2 Lonza Major Business
    • 2.1.3 Lonza Mammalian Process Development Product and Solutions
    • 2.1.4 Lonza Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Lonza Recent Developments and Future Plans
  • 2.2 Sigma-Aldrich
    • 2.2.1 Sigma-Aldrich Details
    • 2.2.2 Sigma-Aldrich Major Business
    • 2.2.3 Sigma-Aldrich Mammalian Process Development Product and Solutions
    • 2.2.4 Sigma-Aldrich Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sigma-Aldrich Recent Developments and Future Plans
  • 2.3 Tanvex
    • 2.3.1 Tanvex Details
    • 2.3.2 Tanvex Major Business
    • 2.3.3 Tanvex Mammalian Process Development Product and Solutions
    • 2.3.4 Tanvex Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Tanvex Recent Developments and Future Plans
  • 2.4 Scorpius BioManufacturing
    • 2.4.1 Scorpius BioManufacturing Details
    • 2.4.2 Scorpius BioManufacturing Major Business
    • 2.4.3 Scorpius BioManufacturing Mammalian Process Development Product and Solutions
    • 2.4.4 Scorpius BioManufacturing Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Scorpius BioManufacturing Recent Developments and Future Plans
  • 2.5 AGC Biologics
    • 2.5.1 AGC Biologics Details
    • 2.5.2 AGC Biologics Major Business
    • 2.5.3 AGC Biologics Mammalian Process Development Product and Solutions
    • 2.5.4 AGC Biologics Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 AGC Biologics Recent Developments and Future Plans
  • 2.6 Kemwell
    • 2.6.1 Kemwell Details
    • 2.6.2 Kemwell Major Business
    • 2.6.3 Kemwell Mammalian Process Development Product and Solutions
    • 2.6.4 Kemwell Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Kemwell Recent Developments and Future Plans
  • 2.7 KBI Biopharma
    • 2.7.1 KBI Biopharma Details
    • 2.7.2 KBI Biopharma Major Business
    • 2.7.3 KBI Biopharma Mammalian Process Development Product and Solutions
    • 2.7.4 KBI Biopharma Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 KBI Biopharma Recent Developments and Future Plans
  • 2.8 Avid Bioservices
    • 2.8.1 Avid Bioservices Details
    • 2.8.2 Avid Bioservices Major Business
    • 2.8.3 Avid Bioservices Mammalian Process Development Product and Solutions
    • 2.8.4 Avid Bioservices Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Avid Bioservices Recent Developments and Future Plans
  • 2.9 BIBITEC
    • 2.9.1 BIBITEC Details
    • 2.9.2 BIBITEC Major Business
    • 2.9.3 BIBITEC Mammalian Process Development Product and Solutions
    • 2.9.4 BIBITEC Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 BIBITEC Recent Developments and Future Plans
  • 2.10 FyoniBio
    • 2.10.1 FyoniBio Details
    • 2.10.2 FyoniBio Major Business
    • 2.10.3 FyoniBio Mammalian Process Development Product and Solutions
    • 2.10.4 FyoniBio Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 FyoniBio Recent Developments and Future Plans
  • 2.11 3P Bio
    • 2.11.1 3P Bio Details
    • 2.11.2 3P Bio Major Business
    • 2.11.3 3P Bio Mammalian Process Development Product and Solutions
    • 2.11.4 3P Bio Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 3P Bio Recent Developments and Future Plans
  • 2.12 GTP Bioways
    • 2.12.1 GTP Bioways Details
    • 2.12.2 GTP Bioways Major Business
    • 2.12.3 GTP Bioways Mammalian Process Development Product and Solutions
    • 2.12.4 GTP Bioways Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 GTP Bioways Recent Developments and Future Plans
  • 2.13 FUJIFILM Diosynth Biotechnologies
    • 2.13.1 FUJIFILM Diosynth Biotechnologies Details
    • 2.13.2 FUJIFILM Diosynth Biotechnologies Major Business
    • 2.13.3 FUJIFILM Diosynth Biotechnologies Mammalian Process Development Product and Solutions
    • 2.13.4 FUJIFILM Diosynth Biotechnologies Mammalian Process Development Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Mammalian Process Development Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Mammalian Process Development by Company Revenue
    • 3.2.2 Top 3 Mammalian Process Development Players Market Share in 2025
    • 3.2.3 Top 6 Mammalian Process Development Players Market Share in 2025
  • 3.3 Mammalian Process Development Market: Overall Company Footprint Analysis
    • 3.3.1 Mammalian Process Development Market: Region Footprint
    • 3.3.2 Mammalian Process Development Market: Company Product Type Footprint
    • 3.3.3 Mammalian Process Development Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Mammalian Process Development Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Mammalian Process Development Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Mammalian Process Development Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Mammalian Process Development Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Mammalian Process Development Consumption Value by Type (2021-2032)
  • 6.2 North America Mammalian Process Development Market Size by Application (2021-2032)
  • 6.3 North America Mammalian Process Development Market Size by Country
    • 6.3.1 North America Mammalian Process Development Consumption Value by Country (2021-2032)
    • 6.3.2 United States Mammalian Process Development Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Mammalian Process Development Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Mammalian Process Development Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Mammalian Process Development Consumption Value by Type (2021-2032)
  • 7.2 Europe Mammalian Process Development Consumption Value by Application (2021-2032)
  • 7.3 Europe Mammalian Process Development Market Size by Country
    • 7.3.1 Europe Mammalian Process Development Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Mammalian Process Development Market Size and Forecast (2021-2032)
    • 7.3.3 France Mammalian Process Development Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Mammalian Process Development Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Mammalian Process Development Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Mammalian Process Development Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Mammalian Process Development Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Mammalian Process Development Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Mammalian Process Development Market Size by Region
    • 8.3.1 Asia-Pacific Mammalian Process Development Consumption Value by Region (2021-2032)
    • 8.3.2 China Mammalian Process Development Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Mammalian Process Development Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Mammalian Process Development Market Size and Forecast (2021-2032)
    • 8.3.5 India Mammalian Process Development Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Mammalian Process Development Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Mammalian Process Development Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Mammalian Process Development Consumption Value by Type (2021-2032)
  • 9.2 South America Mammalian Process Development Consumption Value by Application (2021-2032)
  • 9.3 South America Mammalian Process Development Market Size by Country
    • 9.3.1 South America Mammalian Process Development Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Mammalian Process Development Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Mammalian Process Development Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Mammalian Process Development Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Mammalian Process Development Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Mammalian Process Development Market Size by Country
    • 10.3.1 Middle East & Africa Mammalian Process Development Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Mammalian Process Development Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Mammalian Process Development Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Mammalian Process Development Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Mammalian Process Development Market Drivers
  • 11.2 Mammalian Process Development Market Restraints
  • 11.3 Mammalian Process Development Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Mammalian Process Development Industry Chain
  • 12.2 Mammalian Process Development Upstream Analysis
  • 12.3 Mammalian Process Development Midstream Analysis
  • 12.4 Mammalian Process Development Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Mammalian Process Development market size was valued at US$ 176 million in 2025 and is forecast to a readjusted size of US$ 208 million by 2032 with a CAGR of 2.4% during review period.
    Mammalian Process Development is a development and optimization service for mammalian cell production systems, designed to support the research and development and large-scale production of biopharmaceuticals (such as monoclonal antibodies, recombinant proteins, gene and cell therapies, etc.). By establishing efficient cell culture processes, upstream production processes, downstream separation and purification processes, and a comprehensive quality control system, this service can increase production, ensure product quality, and meet regulatory requirements. Mammalian Process Development covers the entire process from early laboratory research to large-scale commercial production, and is one of the core links in modern biopharmaceuticals.
    This report is a detailed and comprehensive analysis for global Mammalian Process Development market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Mammalian Process Development market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Mammalian Process Development market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Mammalian Process Development market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Mammalian Process Development market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Mammalian Process Development
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Mammalian Process Development market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Sigma-Aldrich, Tanvex, Scorpius BioManufacturing, AGC Biologics, Kemwell, KBI Biopharma, Avid Bioservices, BIBITEC, FyoniBio, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Mammalian Process Development market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Upstream Process Development
    Downstream Process Development
    Market segment by Application
    Vaccine Development
    Biosimilar Drug Development
    Others
    Market segment by players, this report covers
    Lonza
    Sigma-Aldrich
    Tanvex
    Scorpius BioManufacturing
    AGC Biologics
    Kemwell
    KBI Biopharma
    Avid Bioservices
    BIBITEC
    FyoniBio
    3P Bio
    GTP Bioways
    FUJIFILM Diosynth Biotechnologies
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Mammalian Process Development product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Mammalian Process Development, with revenue, gross margin, and global market share of Mammalian Process Development from 2021 to 2026.
    Chapter 3, the Mammalian Process Development competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Mammalian Process Development market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Mammalian Process Development.
    Chapter 13, to describe Mammalian Process Development research findings and conclusion.

    Buy now